Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

A switch-variant model integrates the functions of an autoimmune variant of the phosphatase PTPN22.

Vang T, Nielsen J, Burn GL.

Sci Signal. 2018 Apr 17;11(526). pii: eaat0936. doi: 10.1126/scisignal.aat0936. Review.

PMID:
29666305
2.

Effect of a physical activity intervention on suPAR levels: A randomized controlled trial.

Rohde C, Polcwiartek C, Andersen E, Vang T, Nielsen J.

J Sci Med Sport. 2018 Mar;21(3):286-290. doi: 10.1016/j.jsams.2017.06.018. Epub 2017 Jul 4.

PMID:
28728886
3.

Antipsychotic-associated psoriatic rash - a case report.

Bujor CE, Vang T, Nielsen J, Schjerning O.

BMC Psychiatry. 2017 Jul 4;17(1):242. doi: 10.1186/s12888-017-1411-2.

4.

Diabetic ketoacidosis and diabetes associated with antipsychotic exposure among a previously diabetes-naive population with schizophrenia: a nationwide nested case-control study.

Polcwiartek C, Kragholm K, Rohde C, Hashemi N, Vang T, Nielsen J.

Diabetologia. 2017 Sep;60(9):1678-1690. doi: 10.1007/s00125-017-4320-5. Epub 2017 Jun 7.

PMID:
28593353
5.

Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.

Polcwiartek C, Vang T, Bruhn CH, Hashemi N, Rosenzweig M, Nielsen J.

Psychopharmacology (Berl). 2016 Oct;233(21-22):3663-3672. Epub 2016 Sep 4. Review.

PMID:
27592232
6.

Eosinophilic myocarditis during treatment with olanzapine - report of two possible cases.

Vang T, Rosenzweig M, Bruhn CH, Polcwiartek C, Kanters JK, Nielsen J.

BMC Psychiatry. 2016 Mar 17;16:70. doi: 10.1186/s12888-016-0776-y.

7.

Soluble urokinase-type plasminogen activator receptor levels in patients with schizophrenia.

Nielsen J, Røge R, Pristed SG, Viuff AG, Ullum H, Thørner LW, Werge T, Vang T.

Schizophr Bull. 2015 May;41(3):764-71. doi: 10.1093/schbul/sbu118. Epub 2014 Aug 25.

8.

The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses.

Vang T, Landskron J, Viken MK, Oberprieler N, Torgersen KM, Mustelin T, Tasken K, Tautz L, Rickert RC, Lie BA.

Hum Immunol. 2013 May;74(5):574-85. doi: 10.1016/j.humimm.2012.12.017. Epub 2013 Jan 17.

9.

LYP inhibits T-cell activation when dissociated from CSK.

Vang T, Liu WH, Delacroix L, Wu S, Vasile S, Dahl R, Yang L, Musumeci L, Francis D, Landskron J, Tasken K, Tremblay ML, Lie BA, Page R, Mustelin T, Rahmouni S, Rickert RC, Tautz L.

Nat Chem Biol. 2012 Mar 18;8(5):437-46. doi: 10.1038/nchembio.916.

10.

T cell-signaling network analysis reveals distinct differences between CD28 and CD2 costimulation responses in various subsets and in the MAPK pathway between resting and activated regulatory T cells.

Kalland ME, Oberprieler NG, Vang T, Taskén K, Torgersen KM.

J Immunol. 2011 Nov 15;187(10):5233-45. doi: 10.4049/jimmunol.1101804. Epub 2011 Oct 19.

11.

Inhibition of lymphoid tyrosine phosphatase by benzofuran salicylic acids.

Vang T, Xie Y, Liu WH, Vidović D, Liu Y, Wu S, Smith DH, Rinderspacher A, Chung C, Gong G, Mustelin T, Landry DW, Rickert RC, Schürer SC, Deng SX, Tautz L.

J Med Chem. 2011 Jan 27;54(2):562-71. doi: 10.1021/jm101004d. Epub 2010 Dec 29.

12.

Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells.

Wu S, Vossius S, Rahmouni S, Miletic AV, Vang T, Vazquez-Rodriguez J, Cerignoli F, Arimura Y, Williams S, Hayes T, Moutschen M, Vasile S, Pellecchia M, Mustelin T, Tautz L.

J Med Chem. 2009 Nov 12;52(21):6716-23. doi: 10.1021/jm901016k. Erratum in: J Med Chem. 2009 Dec 24;52(24):8058.

13.

The heterotrimeric G-protein alpha-subunit Galphaq regulates TCR-mediated immune responses through an Lck-dependent pathway.

Ngai J, Methi T, Andressen KW, Levy FO, Torgersen KM, Vang T, Wettschureck N, Taskén K.

Eur J Immunol. 2008 Nov;38(11):3208-18. doi: 10.1002/eji.200838195.

14.

TCR-induced downregulation of protein tyrosine phosphatase PEST augments secondary T cell responses.

Arimura Y, Vang T, Tautz L, Williams S, Mustelin T.

Mol Immunol. 2008 Jun;45(11):3074-84. doi: 10.1016/j.molimm.2008.03.019. Epub 2008 May 5.

15.

Protein tyrosine phosphatases in autoimmunity.

Vang T, Miletic AV, Arimura Y, Tautz L, Rickert RC, Mustelin T.

Annu Rev Immunol. 2008;26:29-55. doi: 10.1146/annurev.immunol.26.021607.090418. Review.

PMID:
18303998
16.

A weak Lck tail bite is necessary for Lck function in T cell antigen receptor signaling.

Nika K, Tautz L, Arimura Y, Vang T, Williams S, Mustelin T.

J Biol Chem. 2007 Dec 7;282(49):36000-9. Epub 2007 Sep 26.

17.

Protein tyrosine phosphatase PTPN22 in human autoimmunity.

Vang T, Miletic AV, Bottini N, Mustelin T.

Autoimmunity. 2007 Sep;40(6):453-61. Review.

PMID:
17729039
18.

Hypophosphorylated TCR/CD3zeta signals through a Grb2-SOS1-Ras pathway in Lck knockdown cells.

Methi T, Ngai J, Vang T, Torgersen KM, Taskén K.

Eur J Immunol. 2007 Sep;37(9):2539-48.

19.

PTPome-wide functional RNA interference screening methods.

Opaluch AM, Aza-Blanc P, Vang T, Williams S, Tautz L, Milan L, Mustelin T.

Methods. 2007 Jul;42(3):306-12.

PMID:
17532518
20.

Verified predominance of slow acetylator phenotype N-acetyltransferase 2 (NAT2) in a Hmong population residing in Minnesota.

Straka RJ, Burkhardt RT, Lang NP, Vang T, Hadsall KZ, Tsai MY.

Biopharm Drug Dispos. 2006 Sep;27(6):299-304.

PMID:
16799928
21.

Role of PTPN22 in type 1 diabetes and other autoimmune diseases.

Bottini N, Vang T, Cucca F, Mustelin T.

Semin Immunol. 2006 Aug;18(4):207-13. Epub 2006 May 11. Review.

PMID:
16697661
22.

Short-interfering RNA-mediated Lck knockdown results in augmented downstream T cell responses.

Methi T, Ngai J, Mahic M, Amarzguioui M, Vang T, Tasken K.

J Immunol. 2005 Dec 1;175(11):7398-406.

23.

Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant.

Vang T, Congia M, Macis MD, Musumeci L, Orrú V, Zavattari P, Nika K, Tautz L, Taskén K, Cucca F, Mustelin T, Bottini N.

Nat Genet. 2005 Dec;37(12):1317-9. Epub 2005 Nov 6.

PMID:
16273109
24.

Removal of C-terminal SRC kinase from the immune synapse by a new binding protein.

Rahmouni S, Vang T, Alonso A, Williams S, van Stipdonk M, Soncini C, Moutschen M, Schoenberger SP, Mustelin T.

Mol Cell Biol. 2005 Mar;25(6):2227-41.

25.

Protein tyrosine phosphatases and the immune response.

Mustelin T, Vang T, Bottini N.

Nat Rev Immunol. 2005 Jan;5(1):43-57. Review.

PMID:
15630428
26.

TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling.

Abrahamsen H, Baillie G, Ngai J, Vang T, Nika K, Ruppelt A, Mustelin T, Zaccolo M, Houslay M, Taskén K.

J Immunol. 2004 Oct 15;173(8):4847-58.

27.

Knockdown of C-terminal Src kinase by siRNA-mediated RNA interference augments T cell receptor signaling in mature T cells.

Vang T, Abrahamsen H, Myklebust S, Enserink J, Prydz H, Mustelin T, Amarzguioui M, Tasken K.

Eur J Immunol. 2004 Aug;34(8):2191-9.

28.

PKAI as a potential target for therapeutic intervention.

Taskén K, Hansson V, Aukrust P, Frøland S, Skålhegg BS, Müller F, Tobin D, Vang T, Torgersen KM, Aandahl EM.

Drug News Perspect. 2000 Feb;13(1):12-8.

PMID:
12937648
29.

Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase a inhibits T cell receptor signaling.

Vang T, Abrahamsen H, Myklebust S, Horejsí V, Taskén K.

J Biol Chem. 2003 May 16;278(20):17597-600. Epub 2003 Mar 28.

30.

A human whole blood model of LPS-mediated suppression of T cell activation.

Yaqub S, Solhaug V, Vang T, Solberg R, Aasen A, Taskén K, Wang JE.

Med Sci Monit. 2003 Mar;9(3):BR120-6.

PMID:
12640334
31.

Protein kinase A intersects SRC signaling in membrane microdomains.

Abrahamsen H, Vang T, Taskén K.

J Biol Chem. 2003 May 9;278(19):17170-7. Epub 2003 Feb 26.

32.

Activation of C-terminal Src kinase (Csk) by phosphorylation at serine-364 depends on the Csk-Src homology 3 domain.

Yaqub S, Abrahamsen H, Zimmerman B, Kholod N, Torgersen KM, Mustelin T, Herberg FW, Taskén K, Vang T.

Biochem J. 2003 May 15;372(Pt 1):271-8.

33.

Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I.

Aandahl EM, Moretto WJ, Haslett PA, Vang T, Bryn T, Tasken K, Nixon DF.

J Immunol. 2002 Jul 15;169(2):802-8.

34.

[Boerhaave's syndrome--an unusual cause of acute retrosternal pain].

Vang T, Våge V, Sletteskog N.

Tidsskr Nor Laegeforen. 2002 Feb 28;122(6):603-4. Norwegian.

PMID:
11998712
35.

Molecular mechanisms for protein kinase A-mediated modulation of immune function.

Torgersen KM, Vang T, Abrahamsen H, Yaqub S, Taskén K.

Cell Signal. 2002 Jan;14(1):1-9. Review.

PMID:
11747983
36.

Release from tonic inhibition of T cell activation through transient displacement of C-terminal Src kinase (Csk) from lipid rafts.

Torgersen KM, Vang T, Abrahamsen H, Yaqub S, Horejsí V, Schraven B, Rolstad B, Mustelin T, Taskén K.

J Biol Chem. 2001 Aug 3;276(31):29313-8. Epub 2001 Jun 4.

37.

Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor.

Vang T, Torgersen KM, Sundvold V, Saxena M, Levy FO, Skålhegg BS, Hansson V, Mustelin T, Taskén K.

J Exp Med. 2001 Feb 19;193(4):497-507.

38.

Kinetic properties of the C-terminal Src kinase, p50csk.

Vang T, Taskén K, Skålhegg BS, Hansson V, Levy FO.

Biochim Biophys Acta. 1998 May 19;1384(2):285-93.

PMID:
9659389
39.

Structure, function, and regulation of human cAMP-dependent protein kinases.

Taskén K, Skålhegg BS, Taskén KA, Solberg R, Knutsen HK, Levy FO, Sandberg M, Orstavik S, Larsen T, Johansen AK, Vang T, Schrader HP, Reinton NT, Torgersen KM, Hansson V, Jahnsen T.

Adv Second Messenger Phosphoprotein Res. 1997;31:191-204. Review.

PMID:
9344252
40.

Medication compliance, antidepressant blood levels, and side effects in Southeast Asian patients.

Kroll J, Linde P, Habenicht M, Chan S, Yang M, Vang T, Souvannasoth L, Nguyen T, Ly M, Nguyen H, et al.

J Clin Psychopharmacol. 1990 Aug;10(4):279-83.

PMID:
2286700
41.

Depression and posttraumatic stress disorder in Southeast Asian refugees.

Kroll J, Habenicht M, Mackenzie T, Yang M, Chan S, Vang T, Nguyen T, Ly M, Phommasouvanh B, Nguyen H, et al.

Am J Psychiatry. 1989 Dec;146(12):1592-7.

PMID:
2589553
42.

Acculturation and mental health: a study of Hmong refugees at 1.5 and 3.5 years postmigration.

Westermeyer J, Neider J, Vang TF.

Soc Sci Med. 1984;18(1):87-93.

PMID:
6695205
43.

Hmong refugees in Minnesota: sex roles and mental health.

Westermeyer J, Bouafuely M, Vang TF.

Med Anthropol. 1984 Fall;8(4):229-45. No abstract available.

PMID:
6536855
44.

Symptom change over time among Hmong refugees: psychiatric patients versus nonpatients.

Westermeyer J, Vang TF, Neider J.

Psychopathology. 1984;17(4):168-77.

PMID:
6528011
45.

Hmong refugees in Minnesota. Characteristics and self perceptions.

Westermeyer J, Vang TF, Lyfong G.

Minn Med. 1983 Jul;66(7):431-9. No abstract available.

PMID:
6621514
46.
47.

Refugees who do and do not seek psychiatric care. An analysis of premigratory and postmigratory characteristics.

Westermeyer J, Vang TF, Neider J.

J Nerv Ment Dis. 1983 Feb;171(2):86-91.

PMID:
6822823

Supplemental Content

Support Center